The measure of you

Explore how digital biomakers are changing the way we understand health

Digital tools, such as smartphones or wearables, can now continually measure and collect health information - or 'digital biomakers' - from patients

365 days living with a disease

Every dot on this graph represents a day in the life of a patient

People living with a condition may only see a physician once or twice a year and may not entirely remember how they have felt on a specific day. Digital biomarkers help to provide a more comprehensive picture of how you feel on a day-to-day basis.

Digital biomarkers are changing how future medicines will be developed and could lead to more personalised treatments. This will transform the lives of patients.
Christian Gossens
Head of Digital Biomarkers, Roche Pharma Research & Early Development
Every new symptom I notice I write down and the day I go to my appointment I go with a little piece of paper so I don’t forget anything.
Martina Ribera, 49
Diagnosed with multiple sclerosis 20 years ago

Many of us find it hard to remember what we had for breakfast yesterday, what we were doing last Monday at 9am or whether we slept well two weeks ago. But what if our health depended on it?

People living with a chronic condition may often not see a doctor for months or years at a time. This means they face the almost impossible task of trying to remember the sometimes subtle daily changes in their symptoms between doctor visits.

The challenge doctors face is trying to see exactly what is happening, hidden away inside the brain and central nervous system of patients. Being able to track and accurately measure any changes – could lead to ways to slow, and even prevent, irreversible disease progression for patients.

Patient perspective: Shining light on a hidden condition

As a doctor, it can sometimes be difficult to know if I am on the right track with treatment for patients. A phone in the pocket doing frequent assessments would allow me to start fine tuning.
Parkinson’s expert Dr. Ron Postuma
Associate professor in the Department of Neurology and Neurosurgery at McGill University in Montreal, Canada

Digital biomarkers can build on existing tests that patients and clinicians use, with other day-to-day passive monitoring. By combining this information with what they or their family are noticing, they can get a more complete picture.

Physician perspective: Fine-tuning treatment with constant monitoring

Sensor technologies give us a much fuller and more precise picture of patients’ disease and response to treatment in our trials.
Cognitive neuroscientist Kirsten Taylor
Biomarker and Experimental Medicine Leader at Roche.

Advances in wearable devices, such as phones, watches, textiles or delivery devices, which track a patient’s clinically relevant signals and monitor for symptoms, have the potential to vastly accelerate clinical development.

Because the data collected is objective and uses minimal patient involvement, clinical trials can potentially become more precise, faster and smaller.

Help us to change the future of healthcare

With new positions available in the Digital Biomarkers field at Roche, we’re seeking future-thinking innovators - digital technology and science specialists who can apply their expertise to transform some of the most challenging health conditions today.

Ignacio Fernandez Garcia, a Human Resources Talent Scout at Roche and former digital biomarker scientist, says: “With technology being seen as a core component in the future delivery of healthcare, Roche is looking to recruit people who see beyond the traditional realms of research - who are able to think about how new technologies could improve both research and the lives of patients.”

This evolution will inspire creative minds to rethink healthcare and bring completely new business models into reach. Technology is no longer a limiting factor; it's a rich toolbox. Imagination will unlock its potential.

Scientist perspective: Today's insights for tomorrow's treatments

Discover more